Skip to main content

Table 5 Agreement between CLART and LA in 401 women with abnormal cytology

From: Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study

LA

CLART

Total

High-risk genotypes

Low-risk genotypes

No genotypesa

High-risk genotypes

306

12

8

326 (81%)

Low-risk genotypes

5

41

8

54 (13%)

No genotypes a

0

1

20

21 (5%)

Total

311 (78%)

54 (13%)

36 (9%)

401 (100%)

  1. aOr genotypes not detectable by both CLART and LA (CLART: 43, 44, 85, 89; LA: 55, 64, 67, 69, IS39, CP6108).